Predicting the clinical outcome of allogeneic hematopoietic stem cell transplantation: The long and winding road toward validated immune biomarkers

A. Forcina, M. Noviello, M. R. Carbone, Chiara Bonini, Attilio Bondanza

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The clinical outcome of allogeneic hematopoietic stem cell transplantation (HSCT) is strongly influenced from the potential complications arising during the delicate phase of post-transplant immune restoration. The quantitative aspects of immune-cell repopulation after HSCT and the qualitative features their functional restitution have been extensively reported. Nevertheless, measurable immune biomarkers predicting the clinical outcome of HSCT await formal validation. The aim of this review is an appraisal of most studies published so far on the predictive value of different T and NK-cell biomarkers after HSCT with emphasis on defined thresholds endorsed by multivariate analysis.

Original languageEnglish
Article numberArticle 71
JournalFrontiers in Immunology
Volume4
Issue numberMAR
DOIs
Publication statusPublished - 2013

Fingerprint

Hematopoietic Stem Cell Transplantation
Biomarkers
Natural Killer Cells
Multivariate Analysis
Transplants

Keywords

  • Allogeneic hematopoietic stem cell transplantation
  • Biomarkers
  • Graft-versus-host disease
  • Immune reconstitution
  • Opportunistic infections

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Predicting the clinical outcome of allogeneic hematopoietic stem cell transplantation : The long and winding road toward validated immune biomarkers. / Forcina, A.; Noviello, M.; Carbone, M. R.; Bonini, Chiara; Bondanza, Attilio.

In: Frontiers in Immunology, Vol. 4, No. MAR, Article 71, 2013.

Research output: Contribution to journalArticle

@article{8d7702fff56c4cdcb9c08f17adcaf49e,
title = "Predicting the clinical outcome of allogeneic hematopoietic stem cell transplantation: The long and winding road toward validated immune biomarkers",
abstract = "The clinical outcome of allogeneic hematopoietic stem cell transplantation (HSCT) is strongly influenced from the potential complications arising during the delicate phase of post-transplant immune restoration. The quantitative aspects of immune-cell repopulation after HSCT and the qualitative features their functional restitution have been extensively reported. Nevertheless, measurable immune biomarkers predicting the clinical outcome of HSCT await formal validation. The aim of this review is an appraisal of most studies published so far on the predictive value of different T and NK-cell biomarkers after HSCT with emphasis on defined thresholds endorsed by multivariate analysis.",
keywords = "Allogeneic hematopoietic stem cell transplantation, Biomarkers, Graft-versus-host disease, Immune reconstitution, Opportunistic infections",
author = "A. Forcina and M. Noviello and Carbone, {M. R.} and Chiara Bonini and Attilio Bondanza",
year = "2013",
doi = "10.3389/fimmu.2013.00071",
language = "English",
volume = "4",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S.A.",
number = "MAR",

}

TY - JOUR

T1 - Predicting the clinical outcome of allogeneic hematopoietic stem cell transplantation

T2 - The long and winding road toward validated immune biomarkers

AU - Forcina, A.

AU - Noviello, M.

AU - Carbone, M. R.

AU - Bonini, Chiara

AU - Bondanza, Attilio

PY - 2013

Y1 - 2013

N2 - The clinical outcome of allogeneic hematopoietic stem cell transplantation (HSCT) is strongly influenced from the potential complications arising during the delicate phase of post-transplant immune restoration. The quantitative aspects of immune-cell repopulation after HSCT and the qualitative features their functional restitution have been extensively reported. Nevertheless, measurable immune biomarkers predicting the clinical outcome of HSCT await formal validation. The aim of this review is an appraisal of most studies published so far on the predictive value of different T and NK-cell biomarkers after HSCT with emphasis on defined thresholds endorsed by multivariate analysis.

AB - The clinical outcome of allogeneic hematopoietic stem cell transplantation (HSCT) is strongly influenced from the potential complications arising during the delicate phase of post-transplant immune restoration. The quantitative aspects of immune-cell repopulation after HSCT and the qualitative features their functional restitution have been extensively reported. Nevertheless, measurable immune biomarkers predicting the clinical outcome of HSCT await formal validation. The aim of this review is an appraisal of most studies published so far on the predictive value of different T and NK-cell biomarkers after HSCT with emphasis on defined thresholds endorsed by multivariate analysis.

KW - Allogeneic hematopoietic stem cell transplantation

KW - Biomarkers

KW - Graft-versus-host disease

KW - Immune reconstitution

KW - Opportunistic infections

UR - http://www.scopus.com/inward/record.url?scp=84883786323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883786323&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2013.00071

DO - 10.3389/fimmu.2013.00071

M3 - Article

C2 - 23531639

AN - SCOPUS:84883786323

VL - 4

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - MAR

M1 - Article 71

ER -